, Tracking Stock Market Picks
Enter Symbol:
Osiris Therapeutics, Inc. (OSIR) [hlAlert]

down 60.36 %

Osiris Therapeutics, Inc. (OSIR) rated Sell with price target $5 by WBB Securities

Posted on: Friday,  Jan 8, 2010  9:25 AM ET by WBB Securities

WBB Securities rated Sell Osiris Therapeutics, Inc. (NASDAQ: OSIR) on 01/08/2010, when the stock price was $7.19. Since
then, Osiris Therapeutics, Inc. has gained 152.29% as of 01/14/2016's recent price of $18.14.
If you would have followed this WBB Securities's recommendation on OSIR, you would have lost 60.36% of your investment in 2197 days.

Osiris Therapeutics, Inc. (Osiris) is a stem cell therapeutic company, focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic, and cardiovascular areas. The Company?s principal biologic drug candidate, Prochymal, is being evaluated in Phase III clinical trials for three indications, including acute and steroid refractory Graft versus Host Disease (GvHD), Crohn's disease and for the repair of gastrointestinal injury resulting from radiation exposure, and is the only stem cell therapeutic granted both Orphan Drug and Fast Track status by the United States Food and Drug Administration (FDA). Its pipeline of internally developed biologic drug candidates under evaluation also includes Chondrogen for osteoarthritis in the knee. In August 2009, the Company announced the creation of a new Biosurgery Division focused on developing and marketing high-end biological products for use in surgical procedures.

Research from WBB Securities provides investment professionals with up-to-date, in-depth, accurate and insightful reporting of companies that specialize in biotechnology, medical devices and healthcare. Our goal is to provide independent, straight-forward and up-to-date research so you can make educated decisions about your investments.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/31/2011 9:25 AM Sell
6.48 5.00
as of 12/31/2010
1 Week up  16.33 %
1 Month down  -3.81 %
3 Months up  6.45 %
1 YTD up  5.28 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/8/2010 9:25 AM Sell
7.19 5.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy